KRYS

Krystal Biotech, Inc.NASDAQHealthcare

$260.95+0.79%ClosedMarket Cap: $7.63B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-02-25	Guggenheim	—	Buy	—
2026-02-18	Citigroup	—	Buy	—
2026-02-18	Chardan Capital	—	Buy	—
2026-02-17	Jefferies	—	Buy	—
2026-02-02	Goldman Sachs	—	Buy	—
2026-01-22	B of A Securities	—	Buy	—
2026-01-12	Citigroup	—	Buy	—
2026-01-09	TD Cowen	—	Buy	—
2026-01-09	HC Wainwright & Co.	—	Buy	—
2025-11-04	Chardan Capital	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$9.95	$671.5M	7
Sun Dec 31	$13.46	$899.5M	5
Mon Dec 31	$20.30	$1.15B	1
Tue Dec 31	$27.11	$1.45B	1